FDA Inspection 1229926 — Delpharm Dijon
The FDA completed an inspection of Delpharm Dijon on November 19, 2021 in Quetigny. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 19, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Quetigny (France)
Additional Details
Mutual Recognition Agreement (MRA)